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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARYThe reprogramming factors OCT4, SOX2, KLF4, and MYC (OSKM) can reactivate the pluripotency network in terminally differentiated
cells, but also regulate expression of non-pluripotency genes in other contexts, such as the mouse primitive endoderm. The primitive
endoderm is an extraembryonic lineage established in parallel to the pluripotent epiblast in the blastocyst, and is the progenitor pool
for extraembryonic endoderm stem (XEN) cells. We show that OSKM induce expression of endodermal genes, leading to formation of
induced XEN (iXEN) cells, which possess key properties of blastocyst-derived XEN cells, including morphology, transcription profile,
self-renewal, and multipotency. Our data show that iXEN cells arise in parallel to induced pluripotent stem cells, indicating that
OSKM drive cells to two distinct cell fates during reprogramming.INTRODUCTION
Thepluripotency-promoting roleof the reprogramming fac-
tors OCT4, SOX2, KLF4, and MYC (OSKM) is widely appre-
ciated. However, these reprogramming factors also promote
expression of non-pluripotency genes. For example, OCT4
(Pou5f1) directly promotes expression of genes important
for mouse primitive endoderm (Aksoy et al., 2013; Frum
et al., 2013; Le Bin et al., 2014), an extraembryonic lineage
present in the blastocyst, SOX2 indirectly promotes expres-
sion of primitive endoderm genes in the mouse blastocyst
(Wicklow et al., 2014), KLF4 may regulate expression of
primitive endodermgenes in themouseblastocyst (Morgani
andBrickman, 2015), andMYC regulates endodermal genes
in fibroblasts and embryonic stem cells (ESCs) (Neri et al.,
2012; Smith et al., 2010). These observations raise the possi-
bility that OSKM induce expression of endodermal genes in
somatic cells. In support of this idea, several groups have re-
ported that endodermal genes, such as Gata6, Gata4, and
Sox17, are upregulated in protocols used to reprogramfibro-
blasts to induced pluripotent stem cells (iPSCs) (Hou et al.,
2013; Serrano et al., 2013; Zhao et al., 2015).
However, there isnoconsensus as towhether endodermal
gene expression promotes or antagonizes the acquisition of
pluripotency. GATA4 and GATA6 can reportedly substitute
for OCT4 to produce iPSCs (Shu et al., 2013, 2015), arguing
that endodermal genes promote acquisition of pluripo-
tency. Consistent with this, endodermal genes are report-
edly expressed by cells as they become pluripotent during
chemical reprogramming (Hou et al., 2013; Zhao et al.,
2015). By contrast, other evidence suggests that endo-
dermal genes oppose pluripotency during reprogramming.
For example,Gata4 interfereswith the acquisitionof plurip-Stemotency duringOSKM reprogramming (Serrano et al., 2013),
Gata6 is expressed in some partially reprogrammed cells
(Mikkelsen et al., 2008), which are thought to be trapped
in a state between differentiated and pluripotent (Meissner
et al., 2007), andGata6 knockdown led to increased expres-
sion of Nanog in these cells (Mikkelsen et al., 2008). Thus,
endodermal genes have been described as indicators of
incomplete reprogramming. Here, we show that OSKM
drive cells along two distinct and parallel pathways, one
pluripotent and one endodermal.RESULTS AND DISCUSSION
iXEN Cells Display XEN Cell Morphology and Gene
Expression
Weinfectedmouse embryonicfibroblasts (MEFs)or adult tail
tip fibroblasts (TTFs) with retroviruses carryingOSKM (Taka-
hashi and Yamanaka, 2006). Eighteen days after infection,
we observed domed colonies with smooth boundaries (Fig-
ure 1A), which could be propagated as stable iPSC lines (16
out of 28 colonies) and could contribute to normal develop-
ment in chimeras (Figure S1A). In addition,we observed col-
onies that were large and flat, with ragged boundaries (Fig-
ure 1A), and roughly three times more abundant and three
times larger than presumptive iPSC colonies (Figure 1B).
These colonies were visible as early as 6 days after OSKM
infection (Figure S1B). Here, we demonstrate extensive sim-
ilarity between blastocyst-derived extraembryonic endo-
dermstemcell (XEN) cell lines and theMEF-derived cell lines
that we hereafter refer to as induced XEN (iXEN) cells.
We manually isolated putative iXEN cell colonies and
cultured these in ESCmediumwithout leukemia inhibitoryCell Reports j Vol. 6 j 447–455 j April 12, 2016 j ª2016 The Authors 447
Figure 1. OSKM-Induced XEN Cells Arise
during Reprogramming
(A) Fibroblasts were reprogrammed (Taka-
hashi and Yamanaka, 2006), and examined
18 days after OSKM infection.
(B) Frequencies at which iPSC and iXEN cell
colonies were observed. Error bars denote
SE among three reprogrammings each.
(C) Morphology of iXEN cells is similar to
that of blastocyst-derived XEN cells.
(D) Flow cytometric analysis shows that
endodermal proteins are detected in essen-
tially all XEN and iXEN cells (representative
of three independently derived XEN and iXEN
cell lines; brackets, see Figure S1C).
(E) Multidimensional scaling analysis of the
100 most variably expressed genes shows
that iXEN and XEN cell lines are highly
similar, regardless of culture medium, and
dissimilar to MEFs and pluripotent stem cell
lines (Ichida et al., 2009).
(F) Volcano plots show genes whose average
expression level differs significantly (FDR >
0.05, red dotted line) between XEN and iXEN
cell lines in each cell culture medium.
See also Table S1.factor (LIF) (incomplete ESC medium) or in XEN cell me-
dium, which includes FGF4 and HEPARIN, because both
media support the expansion of blastocyst-derived XEN
cells (Kunath et al., 2005). Most iXEN cell colonies main-
tained XEN cell morphology, growing as individual,
dispersed, and apparently motile cells, in either medium
(40 of 51 colonies) (Figure 1C). Aminority of non-iPSC col-
onies (11 of 51 colonies) displayed a mixed mesenchymal
morphology (not shown), reminiscent of partially reprog-
rammed or transformed cells (Meissner et al., 2007;Mikkel-
sen et al., 2008; Sridharan et al., 2009).
Next, we evaluated the expression of endodermal
markers, including GATA6, GATA4, SOX17, SOX7, and
PDGFRA, which were expressed to a similar degree in
both XEN and iXEN cell lines (Figures 1D, S1C, and S1D).
Notably, NANOG was not detected in iXEN cells (Fig-
ure S1D), indicating that iXEN cells are distinct from F-class
(‘‘fuzzy’’) cells, which exist in a state of alternative pluripo-
tency (Tonge et al., 2014). These observations show that
iXEN cells express XEN cell markers.
Finally, we compared iXEN and XEN cell transcriptomes
by RNA sequencing independently derived cell lines, as448 Stem Cell Reports j Vol. 6 j 447–455 j April 12, 2016 j ª2016 The Authowell as MEF, iPSC, and ESC lines. Multidimensional scaling
(MDS) analysis of the 100 most variably expressed genes
showed that iXEN and XEN cell transcriptomes are more
similar to each other than to MEF, ESC, or iPSC transcrip-
tomes, regardless of the medium in which XEN/iXEN cell
lines had been cultured (Figure 1E). Comparing XEN with
iXEN cell lines, we observed significant (false discovery
rate [FDR] < 0.05) differences in the expression levels of
few (146) genes between XEN and iXEN cells cultured in
incomplete ESC medium, and even fewer (16) differences
in XEN cell medium (Figure 1F and Table S1). Expression
of OSKM was not detected in iXEN cells, consistent with
transgene silencing. Pathway and gene ontology (GO)
term analysis of the differentially expressed genes identi-
fied deficiencies in expression of oxidative phosphoryla-
tion and glutathione metabolism genes in iXEN cells
cultured in incomplete ESC medium relative to those
grown inXEN cellmedium (Table S1), which could indicate
deficient iXEN cell proliferation in the absence of growth
factor. No pathways were significantly enriched among
the differentially expressed genes when XEN and iXEN
cells had been cultured in XEN cell medium. Thus, whilers
Figure 2. iXEN Cells Are Self-Renewing
and Multipotent
(A) Proliferation rates for cell lines grown in
each cell culture medium. Error bars denote
SE among three XEN and iXEN cell lines.
(B) VE differentiation assay.
(C) Immunofluorescence shows CDH1 at
cell junctions in differentiated iXEN and XEN
cells, but not in untreated cells (represen-
tative of five independent XEN/iXEN cell
lines, DNA = DAPI). Scale bar, 100 mm.
(D) qPCR analysis of VE gene expression in
differentiated XEN/iXEN cells, relative to un-
treated cell lines. Error bars denote SE for two
differentiations and four qPCRs each.
(E) In vivo differentiation assay.
(F) Summary of chimera results.
(G) iXEN cells contribute to ParE (see Fig-
ure S2 for control chimeras). Scale bar,
100 mm.more transcriptional differences between iXEN, XEN, MEF,
and pluripotent cell lines could become apparent with
deeper biological sampling, we conclude that iXEN and
XEN cell transcriptomes are extremely similar, and that
XEN cell medium better supports conversion of MEFs to
XEN-like cells, consistent the role of FGF4 signaling in
promoting primitive endoderm development in vivo (Cha-
zaud et al., 2006; Kang et al., 2013; Nichols et al., 2009;
Yamanaka et al., 2010).
MEF-Derived XEN Cells Exhibit Stem Cell Properties
Next, we evaluated the self-renewal and multipotency of
iXEN cell lines. In terms of self-renewal, iXEN cell linesStemcould be passaged >35 times in either medium. However,
iXEN cells grew more slowly than XEN cells in incomplete
ESC medium than in XEN cell medium (Figure 2A), consis-
tent with transcriptional profiling predictions. Because LIF
supports the expansion of totipotent ESCs that possess
XEN-like properties (Morgani et al., 2013), we also exam-
ined the proliferation rate of iXEN cells in ESC medium
with LIF, but iXEN cells did not proliferate as rapidly as
XEN cells in this condition (Figure 2A).
Since blastocyst-derived XEN cells can differentiate into
visceral endoderm (VE) or parietal endoderm (ParE) (Artus
et al., 2012; Kunath et al., 2005; Paca et al., 2012), we
evaluated the multipotency of iXEN cells. During the VECell Reports j Vol. 6 j 447–455 j April 12, 2016 j ª2016 The Authors 449
differentiation assay (Figure 2B), iXEN cell lines were able
to differentiate to VE, evidenced by epithelialization, local-
ization of E-cadherin (CDH1) at cell boundaries (Figure 2C),
and upregulation of VE markers (Figure 2D). To evaluate
differentiation to ParE, we made chimeras with XEN and
iXEN cell lines. ESC and iPSC lines were used in parallel
positive controls. In chimeras examined between embry-
onic days 7.5 and 8.5, ESCs and iPSCs contributed to the
epiblast lineage, while XEN cells contributed to ParE with
expected degree and frequency (Figures 2F and S2) (Kunath
et al., 2005; Wamaitha et al., 2015). iXEN cells cultured in
incomplete ESC medium did not contribute to chimeras,
even though XEN cells cultured in incomplete ESC me-
dium did. However, iXEN cell lines cultured in XEN cell
medium contributed to ParE (Figures 2F and 2G) to a
similar extent as XEN cells, indicating that iXEN cells
cultured in FGF4/HEP have XEN cell-like developmental
potential in vivo. These observations underscore the
importance of FGF4/HEP for acquisition of iXEN cell func-
tion. These results also indicate that iXEN cells are distinct
from totipotent cells isolated from pluripotent cell cultures
(Canham et al., 2010; Macfarlan et al., 2012; Morgani et al.,
2013), because iXEN cells did not contribute to epiblast or
trophoblast lineages.
iXEN Cells Are Not Derived from Pre-existing iPSC
Colonies
In monolayers, ESCs can differentiate to XEN-like cells at
low frequency in the presence of LIF (Niakan et al., 2010),
or at high frequency in the absence of LIF and presence of
retinoic acid and activin (RA/activin) (Cho et al., 2012; Nia-
kan et al., 2013). These observations raised the possibility
that iXEN cells were derived from iPSCs. However, this pos-
sibility seemedunlikely for several reasons. First, we derived
iXEN cells in the presence of LIF and absence of RA/activin,
and rare XEN-like cells that arise under these conditions
arise adjacent to, or encircling, the ESC colony from which
they are derived (Niakan et al., 2010). By contrast, iXEN cell
colonies were often located far (R50 mm) from the nearest
iPSC colony (29 of 48 colonies). In addition, we routinely
observed nascent iXEN cell colonies on the sixth day of
OSKM infection (Figures 3A and S1B), which is before we
observed iPSCs. These observations argue that iXEN cells
are derived from MEFs in parallel to iPSCs.
To query the cellular origins of iXEN cells experimen-
tally, we infected 100 wells each containing around ten
tdTOMATO-labeled MEFs per 20,000 unlabeled MEFs
with OSKM retroviruses (Figure 3B). Because MEFs were
labeled sparsely, we predicted that labeled iPSC or iXEN
cell colonies would be relatively rare, enabling us to discern
iXEN cell origins. For example, if iXEN cells were derived
from iPSC colonies, labeled iXEN cell colonies would al-
ways be coincident with labeled iPSC colonies. Alterna-450 Stem Cell Reports j Vol. 6 j 447–455 j April 12, 2016 j ª2016 The Authotively, if iXEN cells were derived from MEFs, labeled iXEN
cell colonies would be observed in wells lacking labeled
iPSC colonies. As expected, most of the wells (85 of 93
wells) contained unlabeled colonies after 18 days of
OSKM infection (Figure 3B). Of the wells containing
labeled colonies, most (7 of 8) contained one labeled
iXEN cell colony and no labeled iPSC colonies. Only in
one well did we observe a labeled iXEN cell colony and a
labeled iPSC colony (1 of 93 wells). Therefore, the majority
of iXEN cells were not derived from iPSC colonies. We do
not exclude the possibility that iXEN cells could be derived
from a cell that transiently expressed pluripotency genes
(Bar-Nur et al., 2015; Maza et al., 2015). Nevertheless, the
presence of iXEN cells in conventional reprogramming
experiments could influence the interpretation of reprog-
ramming outcomes, and underscores the importance of
evaluating cell fates at the clonal level.
All Four Reprogramming Factors Induce XEN Cell Fate
Next, we investigated whether iXEN cells and iPSCs are
induced by similar or different combinations of OSKM.
We evaluated the copy numbers of each transgene by
qPCR analysis of genomic DNA from multiple iXEN cell
and iPSC lines. We observed that the number of OSKM
copies tended to be lower in iXEN cell than in iPSC lines,
although average copy numbers did not differ significantly
(Figure 3C). To determine whether the trend was meaning-
ful, we overexpressed equal levels of OSKM by deriving
MEFs by carrying a doxycycline (dox)-inducible OSKM
cassette (Carey et al., 2010). Interestingly, we observed an
increase in the efficiency of forming both iPSC and iXEN
cell colonies (Figure 3D), indicating that all four reprogram-
ming factors can induce formation of iXEN cells.
GATA6 and GATA4 Facilitate iXEN Cell, but Not iPSC,
Formation
Endodermal genes are reportedly upregulated prior to
pluripotency genes in cultures of MEFs undergoing small-
molecule reprogramming, but not during OSKM reprog-
ramming (Hou et al., 2013; Zhao et al., 2015). However,
we observed GATA6-positive cells 6 days after OSKM infec-
tion (Figure 3A). Moreover, qPCR analysis showed that
endodermal genes, like pluripotency genes, were increas-
ingly upregulated during the 20-day time course of OSKM
reprogramming (Figure 4A), but this did not resolve
whether endodermal genes were expressed within iPSC
progenitors or within a distinct population. We therefore
used flow cytometry to determine whether NANOG-
positive, pre-iPSCs (Bar-Nur et al., 2015) expressed endo-
dermal (GATA6 or SOX17) proteins during reprogram-
ming. We detected NANOG and endodermal proteins in
two largely distinct populations that increased in size
during reprogramming (Figures 4B and S3A–S3C). Neitherrs
Figure 3. OSKM Induce iXEN Cell Fate in
MEFs
(A) Nuclear GATA6, but not NANOG, in
nascent iXEN colony on day 6 of OSKM re-
programming (compared with XEN cell and
ESC controls). Arrowheads point to nuclear
proteins. Scale bar, 100 mm.
(B) Lineage tracing shows that iXEN cells are
not derived from iPSC colonies during OSKM
reprogramming of MEFs (representative of
two experiments).
(C) Absolute qPCR measurement of OSKM
copy numbers in XEN/iXEN cell genomic
DNA.
(D) Comparison of the frequency of iXEN
cell/iPSC colonies after retroviral or trans-
genic overexpression of OSKM on day 18 of
reprogramming. Error bars denote SE; two
cell lines, four experiments each.population was prevalent in MEFs undergoing mock re-
programming (Figure S4A), but both populations were
present and distinct in TTFs during OSKM reprogram-
ming (Figure S4B). These observations suggest that endo-
dermal genes are not expressed in pluripotent cells duringStemOSKM reprogramming, in contrast to evidence that MEFs
undergoing chemical reprogramming transition through
a XEN-like state (Zhao et al., 2015).
To investigate further whether iPSCs transition through
a XEN-like state during OSKM reprogramming, we usedCell Reports j Vol. 6 j 447–455 j April 12, 2016 j ª2016 The Authors 451
Figure 4. MEF-Expressed Endodermal
Genes Promote iXEN Cell Fate
(A) Endodermal (top row) and pluripotency
(lower row) genes are upregulated during
retroviral OSKM reprogramming of MEFs,
measured by qPCR. Error bars denote SE
among three reprogrammings and four
qPCRs.
(B) Flow cytometry analysis of MEFs during
OSKM reprogramming shows that cells ex-
pressing endodermal and pluripotency pro-
teins are largely distinct. Error bars denote
SE between two experiments (see also Fig-
ures S3A–S3C and S4).
(C) Sox17Cre lineage tracing and flow cy-
tometry analysis of cells 20 days after
OSKM infection of MEFs, showing that most
pluripotent (SSEA1-positive) cells never
expressed Sox17. Error bars denote SE
among three reprogrammings (see also
Figure S3D).
(D) Proportions of iPSC and iXEN cell col-
onies after coinfection of MEFs with OSKM
and shRNA constructs. Error bars denote SE
among three reprogrammings (see also
Figure S3E).
(E)Model proposing that endogenous GATA6
expression can push cells toward either iPSC
or iXEN fate during reprogramming.lineage tracing. We retrovirally reprogrammed MEFs car-
rying Cre under the control of the Sox17 promoter (Liao
et al., 2009) and a CRE-sensitive lox-stop-lox-tdTomato re-
porter (Madisen et al., 2010). We predicted that if iPSCs
had expressed endodermal genes during reprogramming,
then most iPSCs would be tdTOMATO-positive 20 days
after OSKM infection because SOX17 is highly and homo-
geneously expressed in iXEN/XEN cells (Figure 1D). How-
ever, we observed that almost all SSEA1-positive cells
were tdTOMATOnegative (Figures 4C and S3D), indicating
that most pluripotent cells had not expressed Sox17 during
reprogramming. Taken together, our observations indicate
that during OSKM reprogramming, endodermal genes are
upregulated in cells that are largely distinct from those
becoming pluripotent. In addition, our observations indi-
cate that pluripotency and XEN pathways are parallel
during OSKM reprogramming, in contrast to the serial,
XEN-to-iPSC pathway that predominates chemical reprog-
ramming (Zhao et al., 2015). Moreover, XEN-like cells
derived during chemical reprogramming cannot be main-
tained inXEN cellmedium (Zhao et al., 2015), highlighting
fundamental differences in cells produced by chemical and
OSKM reprogramming.452 Stem Cell Reports j Vol. 6 j 447–455 j April 12, 2016 j ª2016 The AuthoFinally, we tested the requirement for endodermal genes
in the formation of iXEN cells, with the expectation that
decreasing endodermal gene expression would decrease
the proportion of iXEN cells. We first confirmed substan-
tial knockdown of Gata6, Gata4, Sox17, or Sox7 in estab-
lished XEN cells by transfection of small hairpin RNA
(shRNA)-encoding plasmids (Figure S3E). We then in-
fected MEFs with shRNAs during reprogramming. Knock-
down of Gata6 or Gata4 led to a 2-fold decrease in the
number of iXEN cell colonies obtained (Figure 4D), indi-
cating that these genes are required for iXEN cell fate.
Notably, knockdown of Gata6 also led to a significant in-
crease in the number of iPSC colonies. Thus, endodermal
gene expression interferes with pluripotency during
OSKM reprogramming. We propose that heterogeneous
expression of GATA6 within the MEFs (Figure 4B) could
contribute to different outcomes during reprogramming
(Figure 4E). Alternatively, stochastic differences in the
timing of translation or nuclear localization of the reprog-
ramming factors could influence cell fates. Finally, our ob-
servations suggest that the parallel pluripotency and XEN
pathways compete with, rather than support, each other
during reprogramming. By contrast, paracrine signalingrs
from pluripotent epiblast cells supports the formation of
XEN cell progenitors in the blastocyst (Frum and Ralston,
2015), but our evidence does not support this model dur-
ing reprogramming. We anticipate that identification of
additional mechanisms regulating the balance between
iXEN cell and iPSC fates will inform future efforts to char-
acterize the molecular steps of cell fate specification, and
lead to establishment of new genetic models of reproduc-
tive disorders.EXPERIMENTAL PROCEDURES
Mouse Work
All animal work conformed to the guidelines and regulatory stan-
dards of the Michigan State University Institutional Animal Care
and Use Committee. See Supplemental Experimental Procedures
for strains.
Cell Culture
See Supplemental Experimental Procedures for media recipes.
OSKM retroviruses were produced by transfecting 293T cells with
pCL-ECO and pMXs plasmids encoding OSKM (Addgene). 48 hr
later, supernatant was harvested and qPCR was used to quantify
virus (for primer sequence see Supplemental Experimental Proce-
dures). Approximately 6 3 107 copies OSKM per 40,000 MEFs
were added for 24 hr, and medium was then replaced with MEF
medium, then ESC medium on days 2 and 4, and finally reprog-
ramming medium on day 6 and every other day thereafter. For
dox-induced reprogramming, dox-inducible MEFs were plated at
a density of 50 cells/mm2 on gelatin in MEF medium. After 24 hr
and every 2 days for 16 days thereafter, wells received ESCmedium
with 2 mg/ml dox (Sigma). For sparse labeling, ten tdTOMATO-
labeled MEFs and 20,000 unlabeled MEFs were seeded in each
well of 24-well dishes, then infected with OSKM and examined
18 days later. For lineage tracing, MEFs carrying Sox17tm1(icre)Heli
and Gt(ROSA)26Sortm14(CAG-tdTomato)Hze were infected with OSKM
retrovirus, as described above. shRNAs were cloned into pMXs
and titrated by qPCR (for sequence see Supplemental Experimental
Procedures).
Single-Cell Analyses
Immunostained cells were analyzed on a Becton Dickinson LSR II
or Olympus Fluoview FV1000. Details are available in Supple-
mental Experimental Procedures.
RNA Sequencing and qPCR
cDNA libraries were sequenced to a depth of 25–50 million 50-bp
single-end reads using an Illumina HiSeq 2500. See Supple-
mental Experimental Procedures for details on library prepara-
tion and data processing. The accession number is GEO:
GSE77550.
XEN/iXEN Cell Differentiation
In vitro differentiation followed previously described techniques
(Artus et al., 2012; Paca et al., 2012). To create chimeras,Stemwe injected 15 fluorescently labeled cells into each blastocoel
of unlabeled CD-1 blastocysts, and embryos were then trans-
ferred into the uterus of E2.5 pseudopregnant recipient fe-
males. See Supplemental Experimental Procedures for detailed
protocols.
Statistical Analyses
Unless otherwise stated, t tests were performed for pairwise com-
parisons and ANOVA for multiple pairwise comparisons.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures, four figures, and one table and can be found with
this article online at http://dx.doi.org/10.1016/j.stemcr.2016.
02.003.
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